Follow-on Biologics Market Outlook 2028: Top Companies, Trends and Growth Factors Details for Business Development
29 Aug 2019 - The Global Follow-On
Biologics Market is set to grow
at a specified CAGR during the forecast period. Biologic medicines constitute
significance in terms of patient illnesses. The medicines are grown out of
living cells under laboratory conditions since these are hard to manufacture,
complex and large. The production of biologics is also referred as production
of reference products as it involves inheritance of complex biologics and
exclusive details of manufacturing process.
Follow-on
biologics market is driven by medical advances in treatment for serious
illnesses followed by rise in patient care and surge in medicine manufacture.
In addition, surging demands for low cost biological drugs is stimulating the
market growth. Drug manufacturers are now producing generic biopharmaceuticals,
however, pricing remains a big concern. Increase in costs of healthcare
treatment, expensive form of drugs and rise in population is likely to
stimulate the market growth. However, uncertainties on outcome effect by
consumption of biologics and stringent regulations is more likely to disturb
the market growth during the forecast period.
View Full Report
with TOC @ https://www.millioninsights.com/industry-reports/follow-on-biologics-market
Follow-on
biologics market is segmented by type comprising insulin, growth hormones,
interferons, fertility hormones, fusion proteins and monoclonal antibodies.
Application segment for the market comprises blood disorders, chronic and
autoimmune diseases and oncology diseases.
Geographical
segmentation for the market spans North America, South America, Europe,
Asia-Pacific, Middle East and Africa. North America and Europe market is likely
to grow at a higher rate due to rise in medical infrastructure and increase in
activities pertaining to patient care. Increase in R&D activities for
production of biosimilar & biologics drugs.
The
key players profiled in the follow-on biologics market report are Allergan,
Allozyne, Alteogen, Alvogen, Amarey Novamedical, AstaZeneca, Bionovis,
Biosidus, Bioton, CCM Duopharma, CCL Pharmaceuticals, Celltrion, Chong Kun
Dang, Centocor Ortho Biotech, CinnaGen, Compass Biotechnologies, Ranbaxy,
Syngene Pharmaceutical, Takeda, Zenotech, Zheijan Huahai Pharmaceutical.
Market Segment:
Leading players of Follow-on Biologics
including:
•
Sandoz
•
Pfizer
•
Teva Pahrmaceutical
•
Celltrion
•
Biocon
•
Amgen
•
Samsung Biologics
•
Mylan
•
Dr. Reddy's Laboratories
•
Stada Arzneimittel AG
Market split by Type, can be divided
into:
•
Recombinant Non-glycosylated Proteins
•
Recombinant Glycosylated Proteins
•
Recombinant Peptides
Request Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/follow-on-biologics-market/request-sample
Comments
Post a Comment